Teleflex Incorporated (NYSE:TFX) Receives Average Rating of "Reduce" from Analysts

Shares of Teleflex Incorporated (NYSE:TFX - Get Free Report) have earned a consensus rating of "Reduce" from the twelve analysts that are covering the firm, Marketbeat reports. Two equities research analysts have rated the stock with a sell rating, nine have issued a hold rating and one has assigned a buy rating to the company. The average twelve-month price target among brokerages that have updated their coverage on the stock in the last year is $141.5714.

A number of brokerages have recently weighed in on TFX. Mizuho raised their target price on Teleflex from $130.00 to $135.00 and gave the company a "neutral" rating in a research note on Friday, August 1st. Royal Bank Of Canada upped their price target on shares of Teleflex from $130.00 to $135.00 and gave the stock a "sector perform" rating in a research report on Friday, August 1st. Wall Street Zen cut shares of Teleflex from a "strong-buy" rating to a "buy" rating in a research report on Monday, September 15th. Weiss Ratings reaffirmed a "sell (d+)" rating on shares of Teleflex in a research note on Wednesday, October 8th. Finally, Wells Fargo & Company decreased their price target on shares of Teleflex from $137.00 to $131.00 and set an "equal weight" rating on the stock in a research note on Friday, August 1st.

Teleflex Stock Performance

NYSE:TFX opened at $130.42 on Tuesday. The stock has a market capitalization of $5.76 billion, a P/E ratio of 30.69, a price-to-earnings-growth ratio of 1.79 and a beta of 1.05. The company has a current ratio of 2.41, a quick ratio of 1.44 and a debt-to-equity ratio of 0.42. Teleflex has a 1 year low of $108.90 and a 1 year high of $239.82. The firm has a 50 day moving average of $125.38 and a 200-day moving average of $123.51.

Teleflex (NYSE:TFX - Get Free Report) last released its quarterly earnings results on Thursday, July 31st. The medical technology company reported $3.73 EPS for the quarter, topping analysts' consensus estimates of $3.36 by $0.37. Teleflex had a return on equity of 15.08% and a net margin of 6.31%.The business had revenue of $780.90 million for the quarter, compared to analyst estimates of $771.53 million. During the same period in the prior year, the company earned $3.42 EPS. Teleflex's revenue for the quarter was up 4.2% on a year-over-year basis. Teleflex has set its FY 2025 guidance at 13.900-14.300 EPS. As a group, sell-side analysts anticipate that Teleflex will post 13.98 EPS for the current fiscal year.

Teleflex Announces Dividend

The company also recently disclosed a quarterly dividend, which was paid on Monday, September 15th. Shareholders of record on Friday, August 15th were given a $0.34 dividend. This represents a $1.36 dividend on an annualized basis and a yield of 1.0%. The ex-dividend date was Friday, August 15th. Teleflex's dividend payout ratio (DPR) is presently 32.00%.

Insider Buying and Selling

In other news, Director Jaewon Ryu purchased 1,500 shares of the firm's stock in a transaction that occurred on Tuesday, August 5th. The shares were acquired at an average price of $115.00 per share, for a total transaction of $172,500.00. Following the completion of the acquisition, the director directly owned 3,727 shares in the company, valued at approximately $428,605. The trade was a 67.36% increase in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this hyperlink. Also, CEO Liam Kelly acquired 1,500 shares of the stock in a transaction that occurred on Tuesday, August 5th. The stock was purchased at an average price of $115.07 per share, with a total value of $172,605.00. Following the completion of the transaction, the chief executive officer owned 45,267 shares of the company's stock, valued at approximately $5,208,873.69. This trade represents a 3.43% increase in their ownership of the stock. The disclosure for this purchase can be found here. In the last three months, insiders acquired 5,500 shares of company stock worth $633,590. 1.40% of the stock is currently owned by company insiders.

Institutional Inflows and Outflows

Hedge funds have recently modified their holdings of the business. Janney Montgomery Scott LLC increased its holdings in Teleflex by 5.6% in the first quarter. Janney Montgomery Scott LLC now owns 17,665 shares of the medical technology company's stock valued at $2,441,000 after purchasing an additional 942 shares during the last quarter. QRG Capital Management Inc. increased its position in shares of Teleflex by 35.9% during the first quarter. QRG Capital Management Inc. now owns 2,959 shares of the medical technology company's stock worth $409,000 after acquiring an additional 781 shares in the last quarter. Praxis Investment Management Inc. bought a new stake in shares of Teleflex during the first quarter worth $345,000. Intact Investment Management Inc. acquired a new stake in shares of Teleflex during the first quarter worth $69,000. Finally, RBA Wealth Management LLC bought a new stake in Teleflex in the 1st quarter valued at $2,956,000. Institutional investors own 95.62% of the company's stock.

About Teleflex

Teleflex Incorporated designs, develops, manufactures, and supplies single-use medical devices for common diagnostic and therapeutic procedures in critical care and surgical applications worldwide. The company provides vascular access products that comprise Arrow branded catheters, catheter navigation and tip positioning systems, and intraosseous access systems for the administration of intravenous therapies, the measurement of blood pressure, and the withdrawal of blood samples through a single puncture site.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.